ARCHIVES

FDA Proposes New User Fees for Generics and Biosimilar Products

This article is from The Cancer Letter archive.

Vol. 38 No. 03 | January 20, 2012

Download PDF Visit The Full Archive

Related Articles

32% Rise In Breast Cancer Diagnosis In 1980s Explained By Increase In Mammography Screening

September 21, 1990

Advisors Recommend Listing Estrogen As Carcinogen.

January 12, 2001

In Brief: Michael Boyd Named New DTP Director; Saunders Retires; Michael Friedman New Chief Of CIB

October 7, 1983

Aranesp Improved Anemia In MDS In Phase II Trial

September 30, 2005

Maxine Singer Wins Top SES Award

January 8, 1988

FDA News: FDA Taking Comments on “First Generic” ANDA Process

November 21, 2014